Search

Frank C. Eisenschenk

Examiner (ID: 218)

Most Active Art Unit
1816
Art Unit(s)
1648, 1644, 2899, 1816, 1806
Total Applications
315
Issued Applications
156
Pending Applications
71
Abandoned Applications
88
Applications
StatisticsSubscription-Only

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 3703028 [patent_doc_number] => 05646253 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-08 [patent_title] => 'Recombinant human anti-LK26 antibodies' [patent_app_type] => 1 [patent_app_number] => 8/207996 [patent_app_country] => US [patent_app_date] => 1994-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8245 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/646/05646253.pdf [firstpage_image] =>[orig_patent_app_number] => 207996 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/207996 		Recombinant human anti-LK26 antibodies Mar 7, 1994 Issued
08/206079 IN VITRO ANTIBODY MATURATION Mar 3, 1994 Abandoned
Array ( [id] => 3645439 [patent_doc_number] => 05637493 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-10 [patent_title] => 'Carcinoma associated antigen (SK1) monoclonal antibodies against SK1, methods of producing these antibodies and use therefor' [patent_app_type] => 1 [patent_app_number] => 8/201243 [patent_app_country] => US [patent_app_date] => 1994-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 11431 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/637/05637493.pdf [firstpage_image] =>[orig_patent_app_number] => 201243 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/201243 		Carcinoma associated antigen (SK1) monoclonal antibodies against SK1, methods of producing these antibodies and use therefor Feb 23, 1994 Issued
08/198067 COMPOSITION AND METHOD FOR PREVENTING AND TREATING INFLAMMATION WITH IMMUNOGLOBULIN A Feb 17, 1994 Abandoned
Array ( [id] => 3644427 [patent_doc_number] => 05639455 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-17 [patent_title] => 'Immunosuppressant' [patent_app_type] => 1 [patent_app_number] => 8/197834 [patent_app_country] => US [patent_app_date] => 1994-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 9532 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/639/05639455.pdf [firstpage_image] =>[orig_patent_app_number] => 197834 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/197834 		Immunosuppressant Feb 16, 1994 Issued
Array ( [id] => 3696075 [patent_doc_number] => 05650488 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-22 [patent_title] => 'Polypeptide inhibitor of the replication of HSV' [patent_app_type] => 1 [patent_app_number] => 8/196260 [patent_app_country] => US [patent_app_date] => 1994-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2806 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/650/05650488.pdf [firstpage_image] =>[orig_patent_app_number] => 196260 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/196260 		Polypeptide inhibitor of the replication of HSV Feb 15, 1994 Issued
08/192655 NON-VIRAL VECTOR Feb 6, 1994 Abandoned
Array ( [id] => 3820932 [patent_doc_number] => 05759546 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-02 [patent_title] => 'Treatment of CD4 T-cell mediated conditions' [patent_app_type] => 1 [patent_app_number] => 8/192480 [patent_app_country] => US [patent_app_date] => 1994-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 16 [patent_no_of_words] => 12341 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/759/05759546.pdf [firstpage_image] =>[orig_patent_app_number] => 192480 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/192480 		Treatment of CD4 T-cell mediated conditions Feb 3, 1994 Issued
08/177747 PURIFIED MAMMALIAN CTLA-8 ANTIGENS AND RELATED REAGENTS Jan 4, 1994 Abandoned
08/174674 METHODS FOR PRODUCING ANTIBODY LIBRARIES USING UNIVERSAL OR RANDOMIZED IMMUNOGLOBULIN LIGHT CHAINS Dec 27, 1993 Abandoned
Array ( [id] => 3668140 [patent_doc_number] => 05599909 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-04 [patent_title] => 'Process for reactivating purified membrane proteins' [patent_app_type] => 1 [patent_app_number] => 8/170880 [patent_app_country] => US [patent_app_date] => 1993-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2461 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/599/05599909.pdf [firstpage_image] =>[orig_patent_app_number] => 170880 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/170880 		Process for reactivating purified membrane proteins Dec 20, 1993 Issued
08/169422 METHOD OF TRANSMITTING A BIOLOGICALLY ACTIVE MATERIAL TO A CELL Dec 16, 1993 Abandoned
Array ( [id] => 3548859 [patent_doc_number] => 05545721 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-13 [patent_title] => 'Conjugates for the prevention and treatment of sepsis' [patent_app_type] => 1 [patent_app_number] => 8/169701 [patent_app_country] => US [patent_app_date] => 1993-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 17 [patent_no_of_words] => 40845 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/545/05545721.pdf [firstpage_image] =>[orig_patent_app_number] => 169701 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/169701 		Conjugates for the prevention and treatment of sepsis Dec 16, 1993 Issued
08/167651 EXPRESSION AND PURIFICATION OF HUMAN INTERLEUKIN-3 AND MUTEINS THEREOF Dec 14, 1993 Abandoned
08/167328 MURINE HYBRIDOMA 4A11 AND DIAGNOSTIC ANTIBODY PRODUCED THEREBY Dec 13, 1993 Abandoned
08/165751 METHOD FOR INHIBITING DISEASE ASSOCIATED WITH THE HUMAN IMMUNODEFICIENCY VIRUS THROUGH THE USE OF MONOCLONAL ANTIBODIES DIRECTED AGAINST ANTI-SELF CYTOTOXIC T-LYMPHOCYTES OR THEIR LYTICS Dec 12, 1993 Abandoned
Array ( [id] => 3863657 [patent_doc_number] => 05762905 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'Human neutralizing monoclonal antibodies to respiratory syncytial virus' [patent_app_type] => 1 [patent_app_number] => 8/162102 [patent_app_country] => US [patent_app_date] => 1993-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 20451 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/762/05762905.pdf [firstpage_image] =>[orig_patent_app_number] => 162102 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/162102 		Human neutralizing monoclonal antibodies to respiratory syncytial virus Dec 9, 1993 Issued
08/164302 PRETARGETING METHODS AND COMPOUNDS Dec 8, 1993 Abandoned
08/163188 PRETARGETING METHODS AND COMPOUNDS Dec 6, 1993 Abandoned
08/163184 PRETARGETING METHODS AND COMPOUNDS Dec 6, 1993 Abandoned
Menu